COHERUS BIOSCIENCES INC's ticker is CHRS and the CUSIP is 19249H103. A total of 165 filers reported holding COHERUS BIOSCIENCES INC in Q4 2022. The put-call ratio across all filers is 1.04 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $149,877 | -27.2% | 35,100 | +16.6% | 0.00% | -40.0% |
| Q1 2023 | $205,884 | +84625.9% | 30,100 | -2.0% | 0.01% | -28.6% |
| Q4 2022 | $243 | -99.9% | 30,700 | -0.3% | 0.01% | -22.2% |
| Q3 2022 | $296,000 | +24.9% | 30,800 | -1.0% | 0.01% | +50.0% |
| Q2 2022 | $237,000 | -24.3% | 31,100 | +0.3% | 0.01% | -14.3% |
| Q1 2022 | $313,000 | -36.5% | 31,000 | +0.3% | 0.01% | -36.4% |
| Q4 2021 | $493,000 | +0.2% | 30,900 | +1.0% | 0.01% | -8.3% |
| Q3 2021 | $492,000 | +18.3% | 30,600 | +1.7% | 0.01% | +20.0% |
| Q2 2021 | $416,000 | -2.1% | 30,100 | +3.4% | 0.01% | -9.1% |
| Q1 2021 | $425,000 | -16.2% | 29,100 | -0.3% | 0.01% | -26.7% |
| Q4 2020 | $507,000 | -5.1% | 29,200 | +0.3% | 0.02% | -40.0% |
| Q3 2020 | $534,000 | +80.4% | 29,100 | +75.3% | 0.02% | +38.9% |
| Q2 2020 | $296,000 | – | 16,600 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Atlas Venture Associates IX, LLC | 568,408 | $2,125,846 | 18.08% |
| CM Management, LLC | 548,000 | $2,049,520 | 2.18% |
| AlphaCentric Advisors LLC | 912,500 | $3,412,750 | 1.94% |
| Knott David M Jr | 630,000 | $2,356 | 0.90% |
| COURAGE CAPITAL MANAGEMENT LLC | 50,000 | $187 | 0.63% |
| Bridge City Capital, LLC | 276,224 | $1,033,078 | 0.52% |
| Kohlberg Kravis Roberts & Co. L.P. | 3,036,076 | $11,354,924 | 0.40% |
| Ikarian Capital, LLC | 865,787 | $3,238,043 | 0.39% |
| Aristotle Capital Boston, LLC | 2,342,977 | $8,762,734 | 0.28% |
| TANG CAPITAL MANAGEMENT LLC | 400,000 | $1,496,000 | 0.21% |